A Study of Abemaciclib (LY2835219) in Native Chinese Participants With Advanced and/or Metastatic Cancers
Status:
Completed
Trial end date:
2019-09-03
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety of the study drug known as abemaciclib
in native Chinese participants with advanced and/or metastatic cancers.